Introduction
Disease susceptibility and severity is determined by both inherited and acquired factors. In infectious disease, the importance of inherited factors has been revealed most clearly by classic complete loss of function mutations in genes encoding key immunoregulatory molecules. Most of these types of mutations cause increased susceptibility to infection, eg NADPH oxidase component gp91 phox deficiency in Chronic Granulomatous Disease. 1 However, mutations that cause resistance to infection have also been described, eg CCR5 deficiency due to homozygous inheritance of the inactive allele CCR5⌬32 in HIV/AIDS. 2 A second category of genetic variants may only subtly affect protein expression or function, yet still substantially affect susceptibility or outcome in infectious disease. Examples include genetic variation in immune recognition and effector systems such as the major histocompatibility complex molecules, cytokines/chemokines and their receptors, complement proteins, and microbicidal enzymes. 3 (F110S and C126W) in the open reading frame of FPR1, a gene encoding a phagocyte G protein-coupled receptor named formylpeptide receptor (FPR) which is specific for N-formylpeptide chemoattractants, have been associated with juvenile periodontitis (JP). 4 This disease is characterized by severe oral infections and is associated with defective neutrophil chemotactic responses in vitro. 5 While the effect of these two polymorphisms on FPR expression and function has not been reported, their association with JP and the markedly increased mortality after experimental challenge with Listeria monocytogenes observed in FPR knockout mice suggests a role for FPR in antibacterial host defense. 6 Other polymorphisms in the coding region of FPR1 have been reported based on sporadic cloning and sequencing of genes and cDNAs. However, no systematic exploration of the extent or frequency of polymorphism in this gene has been performed, nor have these other polymorphisms been tested for disease associations. [7] [8] [9] [10] A second structurally related (69% amino acid identity) phagocyte receptor named FPRL1R also binds prototypical N-formylpeptides but with lower affinity than FPR. 11 The corresponding genes, FPR1 and FPRL1, are clustered on chromosome 19q13.3 with a third related putative receptor gene of unknown function expressed in monocytes called FPRL2. 10, 12, 13 The ORFs of both FPR1 and FPRL1 are located on a single exon. 8 The 5Ј non-coding region of FPR1 is located on three exons and the entire gene is ෂ6.5 kb. Outside of the ORF, the gene organization of FPRL1 has not yet been determined. To date, analysis of FPRL1R polymorphism has not been reported.
The aim of the present study was to systematically assess the extent of genetic variation in the coding sequences of FPR1 and FPRL1 and establish the frequencies of common polymorphisms in different racial groups in order to facilitate future disease association studies. We also examined the evolutionary relationship of FPR haplotypes compared to other mammals and within the human species.
Results
Seven SNPs were detected in the ORF of FPR1 by comparison of directly sequenced PCR-amplicons cloned from 26 different individuals (17 Caucasians and nine Blacks) to the reference sequence, GenBank accession number XMF009375. 10 All SNPs were found in more than one individual, indicating that they were likely to represent true variants in the normal population and not polymerase chain reaction (PCR) or cloning artifacts. Five of the FPR1 SNPs were non-synonymous substitutions: (1) a T→C transition at nucleotide 32 (where A in the ATG translation initiation site is considered nucleotide no. 1) resulting in an isoleucine to threonine change at amino acid position 11 (I11T); (2) a G→C transversion at nucleotide 301 resulting in a valine to leucine change at amino acid position 101 (V101L); (3) an A→T transversion at nucleotide 568 resulting in an arginine to tryptophan change at position 190 (R190W); and a C→A transversion at position 1037 resulting in an alanine to glutamate change at position 346 (A346E). Position 576 was triallelic (T, C, or G); T and C both specify asparagine and G specifies lysine at codon 192 (N192K). We also found two synonymous variants, P182P and I116I at nucleotide positions 348 (C→T transition) and 546 (C→A transversion). In contrast when we sequenced the FPRL1 ORF on 44 clones from 36 different random blood donors (23 Caucasians, nine Blacks, three Asians, and one Hispanic) we did not find any variants.
The positions of these FPR1 polymorphic sites are shown in Figure 1 in a structural model of the transmem- brane topography of the receptor based on comparisons with rhodopsin, a related seven transmembrane G protein-coupled receptor for which the crystal structure is known. 14, 15 According to this model, the polymorphisms reside in the extracellular amino terminus (I11T), transmembrane region 3 (V101L and I116I), the 3rd extracellular domain (R190W, N192K, P182P), and the cytoplasmic tail (A346E).
Next, we developed PCR-RFLP genotyping methods for each of the five non-synonymous variants and used them to define FPR1 allele frequencies in different racial groups (Tables 1 and 2 ). We found that all five non-synonymous SNPs were common in all three North American racial groups tested (Caucasian, Asian, and Black). However, there were significant differences in the allelic and genotypic frequencies in the different groups (Table 3, Figure 2 ). The allele frequency for I11T in Asians was significantly lower than for Caucasians (P = 0.0001) and Blacks (P = 0.002). The frequency for V101L for Blacks was significantly lower than for Caucasians (P = 0.005) and Asians (P Ͻ 0.0001), and the frequency for N192K was significantly lower in Asians than for Blacks (P = 0.03). All genotype and allele frequencies were in HardyWeinberg equilibrium for each racial group considered separately.
Our sequencing data revealed that these seven polymorphic sites occurred in 15 distinct haplotypes (Table  4) . Each haplotype was numbered according to its frequency in Caucasian subjects. Our genotyping data also revealed the presence of rare additional haplotypes (H-16 thru H-23) not found by direct sequencing. These are listed on the bottom of Table 4 and we estimate their haplotype frequency at no higher than 2%. Three of these 23 haplotypes (H-3, H-4, and H-9) have been reported previously. 8, 10 H-3 corresponds to the R-26 cDNA and H-4 corresponds to the R-98 cDNA (GenBank numbers M60627 and M37128 respectively) cloned from the promyelocytic leukemia cell line, HL-60. 10 G6 is a genomic clone (GenBank no. L10820) originally reported by our group that contains haplotype 9. 8 In addition three other FPR receptors have been reported, two cDNAs pINF10 and pINF12, and a genomic clone, pINF14 by Perez et al 16 ; however, their DNA sequences have not been deposited in GenBank making it impossible to assign them to a particular haplotype. 16 Studying these three clones, Perez et al 16 identified the FPR1 variants I11T and N192K and also reported R123H and P256E and N293T. 16 We did not find these last three polymorphisms in our sequencing so they could represent PCR, cloning, or sequencing artifacts or could be additional real genetic variants. Finally, two variants in the FPR1 gene, F110S and C126W, have been found in a cohort of JP patients, 80% of whom were African-American. 4 We did not see these variants in a screen of 95 random African-American blood donors screened by RFLP or sequencing which supports the finding that these variants are extremely rare in normal populations.
FPR1 homologues have been cloned and sequenced from other animal species including chimpanzee (Pan troglodytes, GenBank no. X97745), gorilla (Gorilla gorilla, GenBank no. X97736), orangutan (Pongo pygmaeus, GenBank no. X97735), rhesus macaque (Macaca mulatta, GenBank no. X97734), rabbit (Oryctolagus cuniculus, GenBank no. M94549), and mouse (Mus musculus, GenBank no. NMF013521), allowing phylogenetic analysis of FPR poly- TGAGGAAATGACCACGACTGCA  FPR1+163R23  TCCGGAATCCAGCCACCCAGATC   V101L  FPR1+246F24  GGTCAGGAAGGCCATGGGCGGACA  FPR1+373R23  CACAGCGGTCCAGAGCAATGTGG   R190W  FPR1+468F25  CACATTGCCAGTTATCATTCGTGTG  N192K  FPR1+620R44  ATGAACCGGATGATGCGTCTCACCGTCAACATGGCAACGGGTAC   A346E  FPR1+926F23  GGGAGAGGCTGATCCACACCCTT  FPR1+1076R39  GAAAGTGTCCCCCAGCTCCCTCCTCACTTTCCCTGTAAC A PCR-RFLP method was developed in which FPR amplicons containing the given SNP were amplified using the corresponding primers. Underlined nucleotides represent deliberate mismatches to facilitate restriction enzyme based genotyping. 
Amplicons containing the given SNP were digested with the corresponding restriction enzyme. Expected amplicon and restriction fragment sizes are given in base pairs (bp). 
Each haplotype is defined by the shown linkage of nucleotides in the corresponding row, each of which corresponds to the SNP listed at the top of the corresponding column. Haplotypes were determined by direct DNA sequencing (#1-#15) and inferred by SNP genotyping (#16-#23) based on the SNP frequencies observed in sequencing. C and B are the haplotype frequencies found in sequencing FPR1 clones from 17 Caucasian and nine Black individuals. *Indicates the nucleotide is unknown because haplotypes were derived from genotyping which did not include these sites. Similarly, C/T indicates that the genotyping method fails to distinguish these two nucleotides at this position. NO, not observed in sequenced alleles.
morphism. [17] [18] [19] The percentage of sequence identity of the human FPR1 ORF (GenBank no. XMF009375) at the nucleotide level is 99% to Pan troglodytes, 98% to Gorilla gorilla, 97% to Pongo pygmaeus, 95% to Macaca mulatta, 85% to Oryctolagus cuniculus, and 83% to Mus musculus. A comparison of the amino acids present at the seven common polymorphic sites in human FPR1 after alignment reveals some interesting findings (Table 5 ). I11T is isoleucine in all available non-human primate sequences and is valine, a conservative difference, in rabbit and FPR1 codon and amino acid specificities for the listed mammalian species are given for each site found to be polymorphic in humans. Sequence alignment of rabbit and mouse required gaps to be inserted so the sequence of the aligned codons is shown.
mouse. Therefore isoleucine is most likely the ancestral amino acid, but threonine which is larger and more polar and therefore a non-conservative change has become more common in humans. V101L is isoleucine in both the non-human primates and mouse but is valine in rabbit. All three amino acids observed at this site have small aliphatic R groups, and therefore represent conservative differences. I116I and P182P are completely conserved throughout the available phylogeny. R190W is arginine in available non-human primates except for rhesus macaque where, like mouse and rabbit, it is lysine. Lysine and arginine are both basic and presumably arginine is the ancestral amino acid in human. Tryptophan is a nonconservative change, however, because it is neutral and hydrophobic. N192K is lysine in rabbit, mouse and nonhuman primates with the exception of chimpanzee where like the majority of humans it is asparagine. Presumably lysine is the ancestral amino acid. A346E is alanine in nonhuman primates with the exception of rhesus macaque where it is proline; however this site is threonine in the mouse, and as with some humans, glutamate in the rabbit. Therefore this position is more variable than the other six. Glutamate is acidic while alanine is small, neutral and hydrophobic so this is also a non-conservative change. A phylogenetic tree constructed using the neighborjoining method (Mega version 2.0) was performed for the complete open reading frames of all available mammalian FPR1 sequences (Figure 3) . 20 This revealed the expected result of the ape sequences being the most similar to the human haplotypes followed by the macaque monkey, then rabbit and mouse. The low confidence limits on the phylogenies for the evolution of the human haplotypes indicates that there are multiple equally likely possibilities creating uncertainties in their groupings. Figure 4 shows the nucleotide and amino acid sequence of the 15 sequence derived human haplotypes and ape haplotypes arranged by the number of differences with 
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the Pan troglodytes FPR1 sequence at the seven common human polymorphic sites. Figure 5 shows possible evolutionary relationships of the haplotypes based on the principle of parsimony and with a root in Pan troglodytes. Thus, each haplotype described has only one SNP change from the adjacent haplotype and H-x indicates when a hypothetical haplotype is necessary to bridge to observed haplotypes. The analysis shows that H-4 and H-8 are the most likely human ancestral haplotypes, since they both differ by only one nucleotide at the V101L SNP from the P. troglodytes FPR1 haplotype. These two early haplotypes appear to have given rise to two separate clusters. The first cluster from H-4 probably originated haplotypes H-14, H-6 and H-10, followed by the emergence of haplotypes H-7, H-15 and H-5 from H-10. The other cluster of H-3 and H-9 appears most likely to have arisen from H-8. The origins of H-2, H-11, H-12, and H-13 are less certain and could have arisen from multiple haplotypes with an equal likelihood. For example, haplotype H-13 could have arisen from either H-15 or H-5 by a single nucleotide change.
Discussion
Our results demonstrate that the structurally and functionally related phagocyte chemotactic receptors FPR and FPRL1R have undergone dramatically different evolution in humans. Seven common human FPR1 polymorphisms were detected by analysis of complete open reading frames in Caucasians and Blacks, whereas only one human FPRL1 haplotype in Caucasians, Blacks, and Asians could be found. In addition, all seven polymorphisms were common in all three racial groups, but the allele frequencies varied widely among different racial groups. Four of the FPR polymorphisms detected in this study (I11T, V101L, N192K, and E346A) have been previously noted based on sporadic sequencing of cDNA and genomic clones. [7] [8] [9] [10] However our study provides new information about these polymorphisms with regard to genotyping methods, linkage into haplotypes, frequency and distribution in human populations and possible evolutionary history. Moreover this is the first study to screen for FPRL1R polymorphism.
Both FPR and FPRL1R appear to be unusual with regard to the degree of polymorphism they have acquired in human evolution. In a study of 106 nuclear genes Cargill et al 21 reported that on average there is one polymorphism for every 346 basepairs in coding regions, approximately 50% of which are non-synonymous. Thus, in screening the 1.05 kb ORFs of the FPR1 and FPRL1 genes we expected to find ෂ3 polymorphic sites, one to two of which would have been expected to be non-synonymous as opposed to the five non-synonymous and two synonymous changes observed for FPR1 and none of either type for FPRL1. Another way to quantitate genetic variability is to calculate the nucleotide diversity which is defined as the number of nucleotide differences per site between two randomly chosen sequences from a population. 22 The nucleotide diversity in FPR1 is 0.00209, which is about three-fold higher compared to the mean reported for other nuclear genes. 21, 23 Thus, FPR1 is considerably more polymorphic than would have been expected and more of that variation was nonsynonymous than would have been expected. Conversely, FPRL1 is much less polymorphic. Since FPR has Table 4 . Each haplotype differs from the adjacent haplotype by only one SNP change. H-x are hypothetical haplotypes not observed in sequencing. Each sequence specifies the nucleotides present in the corresponding haplotype at each of the seven polymorphic sites in the order: IllT, V101L, I116I, P182P, R190W, N192K, A346E. much higher affinity than FPRL1R for common N-formylpeptide ligands and is probably responsible for initial leukocyte chemotaxis in response to these ligands, 24 the dichotomy in the extent of polymorphism they show may have relevance to their evolution and physiologic function.
The mechanisms responsible for fixing each FPR SNP at such high and variable levels in different racial groups are not clear. However the presence of these polymorphisms in all racial groups tested argues against the possibility of a population bottleneck and in favor of natural selection. Selection pressure would be consistent with the extensive divergence of FPR homologues throughout mammalian evolution that has been noted previously. 24 FPR resembles most other immunoregulatory proteins in this regard, having ෂ3-fold more amino acid sequence divergence between human and mouse forms than the average for proteins from other functional classes. 25 However, it is important to note that proteins which are highly divergent among species are not necessarily highly polymorphic within a species. Perhaps the most extreme examples of this dichotomy are the eosinophil granule proteins ECP and EDN, which are among the most rapidly evolving proteins in mammals yet are not polymorphic in human. 26 Since FPR is highly divergent both within the human species and when compared to other mammals, it is likely that it has been subjected to strong natural selection throughout evolution.
Because this receptor is known to be important in the chemotaxis of neutrophils and monocytes in response to bacterially-derived N-formylpeptides, it is reasonable to speculate that selection may have involved differential susceptibility to or survival after bacterial infection. Epidemic bacterial plagues such as cholera, salmonella, bubonic plague, tuberculosis, and pertussis could be candidate infectious agents creating selective pressure on the evolution of the FPR1 gene. 27 One potential example of such selection at work may be the recent description of the association of FPR polymorphisms F110S and C126W with JP in a cohort of African-Americans and Caucasians. This disease is characterized by severe periodontal bacterial infections with species such as Actinobacillus actinomycetemcomitans. 4 Our failure to identify these polymorphisms in a reasonably large sample of AfricanAmerican random blood donors suggests an extremely strong association with that disease.
The functional consequences of these polymorphisms are largely unknown. The extracellular loops and adjacent portions of the transmembrane domains of FPR have been shown by site-directed mutagenesis, chimeric receptor analysis and photobleaching studies to be involved in N-formylpeptide ligand binding, and the cytoplasmic tail has been shown by truncation mutagenesis to be involved in intracellular signaling. 24, 28 Therefore, SNPs in these domains may affect function. Boulay et al 10 reported small differences in the fMLF binding affinity for haplotypes H-3 and H-4 by transfection of R-26 and R-98 cDNA clones in COS cells; however, Perez et al 7 reported no differences between pINF10 and pINF12. The limitations of these studies are that transfected cells, which often express abnormally high levels of receptor, were used and only one parameter (fMLF binding) of only one of the many potential ligands was studied. Functional analysis of site-directed point mutants of FPR have also been reported but they have not corresponded to any of the naturally occurring variants. [28] [29] [30] No comparative ligand 
Materials and methods

Donors
Peripheral blood mononuclear cells (PBMC) were obtained from anonymous random blood donors at the Warren Grant Magnuson Clinical Center of the National Institutes of Health in Bethesda, Maryland, USA and from healthy volunteers who had provided informed consent as described under the auspices of an NIAID IRB approved protocol. Individuals genotyped by RFLP included 71 North American Caucasians, 74 North American Blacks, and 41 North American Asians. All individuals were classified by self-identified racial group. Genomic DNA was isolated as previously described.
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Cloning and DNA sequencing The complete ORFs of FPR1 and FPRL1 were cloned by PCR from genomic DNA from 26 and 36 random donors respectively using the primer pairs, FPR1−42F22/ FPR1+1063R22 and FPRL1−17F21/FPRL1+1113R24. In this report, primers are described by the name of the amplified gene followed by their position relative to the A in the ATG translation initiation site followed by F or R for forward or reverse and then the number of nucleotides in length and are based on GenBank accession no. L10820 for FPR1 and NMF001462 for FPRL1 primers. PCR of FPR1 and FPRL1 for cloning was perfomed in a 50 l reaction containing 3.5 U of Expand High Fidelity PCR polymerase (Roche, Indianapolis, IN, USA). The reactions were carried out in PCR buffer (Life Technologies, Gaithersburg, MD, USA) containing 1.5 mM MgCl 2 , 200 nM dNTPs, and 15 picomoles of each primer. Genomic DNA was initially denatured at 95°C for 3 min, followed by 35 cycles of 95°C for 1 min for denaturing, 72°C for 1 min for annealing, and 72°C for 1 min for extension. A final extension at 72°C for 10 min was performed.
Amplicons were ligated into the pCR3.1 vector using the Eukaryotic TA cloning kit (Invitrogen, La Jolla, CA, USA). Individual clones were sequenced in both directions using an ABI 377 automated sequencer and the ABI Prism Dye Terminator cycle sequencing system (PE Biosytems, Foster City, CA, USA) using the manufacturer's recommended procedure. To ensure complete bi-directional sequencing, two plasmid based primers (T7 and BGH reverse, Invitrogen) and four additional custom sequencing primers for each receptor were used. FPR1 sequencing primers: FPR1+277F17, FPR1+372R18, FPR1+597F18, and FPR1+736R18 for FPR1 and FPRL1 sequencing primers: FPRL1+279F20, FPRL1+379R17, FPRL1+613F20, and FPRL1+735R20 were used. Sequences were analyzed with the computer program Sequencher 3.1.1 (Gene Codes, Ann Arbor, MI, USA).
PCR-RFLP genotyping
Genotyping of FPR1 variants was performed by PCR amplification of specific polymorphic regions of FPR1 fol-lowed by restriction enzyme digestion (PCR-RFLP). All PCRs were performed in 50 l PCR buffer (Gibco, BRL, Baltimore, MD, USA) containing 1.5 mM MgCl 2 , 200 nM dNTPs, 15 picomoles of each primer (Table 1 ) and 2.5 U of Platinum Taq polymerase (Gibco, BRL). DNA was initially denatured at 94°C for 2 min, followed by 35 cycles of denaturing at 95°C for 30 s, annealing at 68°C for 30 s, and extension at 72°C for 30 s. A final extension at 72°C for 7 min was then performed. RFLP analysis was performed by digesting 5 l of the PCR product overnight with restriction enzymes using buffer conditions and temperatures recommended by the manufacturer. All restriction enzymes were obtained from New England Biolabs (Beverly, MA, USA) except for KpnI which was from Gibco, BRL. The restriction enzymes for each site and the amplicon and restriction fragment sizes are listed in Table 2 .
Statistics
Differences in genotype frequency and analysis of HardyWeinberg equilibrium were performed using the Pearson chi-square test with two degrees of freedom. Nucleotide diversity calculations and phylogenetic tree analysis were performed using the MEGA version 2 program. 20 
